UPDATE : Sunday, February 23, 2020
상단여백
Pfizer wins Champix patent suit against 20 local generics makers
Pfizer won a patent lawsuit against local drugmakers over its antismoking d...
by Jeong Sae-im  |  2019-12-20 16:28
라인
Chemas to research anticancer treatment in Germany
Chemas, a local pharmaceutical company, said that it has completed its prep...
by Lee Han-soo  |  2019-12-20 15:18
라인
Bridge Biotherapeutics seeks IND status for lung cancer treatment
Bridge Biotherapeutics said it has filed an investigational new drug (IND) ...
by Lee Han-soo  |  2019-12-20 14:41
라인
Boehringer Ingelheim stops developing Pharmaxis’ NASH treatment candidate
Boehringer Ingelheim said that it has decided to discontinue its developmen...
by Lee Han-soo  |  2019-12-19 17:42
라인
AstraZeneca, Korean partners launch joint project to accelerate bio-health innovation
AstraZeneca said that it has signed a memorandum of understanding with four...
by Lee Han-soo  |  2019-12-19 17:40
라인
AstraZeneca, SK Holdings celebrates manufacturing partnership
AstraZeneca and SK Holdings said they have reached an important milestone i...
by Lee Han-soo  |  2019-12-19 16:39
라인
Daewoong wins sales approval for Nabota in UAE, Indonesia
Daewoong Pharmaceutical said that it has received sales approval for its bo...
by Lee Han-soo  |  2019-12-19 12:09
라인
Crystal Genomics acquires Hwail as subsidiary
Crystal Genomics said that it has acquired Hwail Pharmaceutical as its subs...
by Lee Han-soo  |  2019-12-18 17:48
라인
4 new botulinum toxins to undergo trials in crowded market
Small and mid-size domestic companies are rushing to develop botulinum toxi...
by Jeong Sae-im  |  2019-12-18 15:29
라인
‘Roche's Xofluza to revolutionize influenza antivirals’
Roche Korea’s Xofluza is a new influenza treatment, a first-in-class, singl...
by Lee Han-soo  |  2019-12-17 16:30
라인
Novartis reaffirms efficacy of Tasigna in treating chronic myelogenous leukemia
Novartis Korea said that it has affirmed the efficacy of Tasigna, a chronic...
by Lee Han-soo  |  2019-12-17 14:48
라인
CDK4/6+fulvestrant combo may get benefit in 1st half of 2020
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi  |  2019-12-17 11:59
라인
CJ Healthcare unites with Standigm to develop AI-based anticancer drugs
CJ Healthcare said that it plans to develop new anticancer drugs jointly wi...
by Lee Han-soo  |  2019-12-17 11:58
라인
Dong-A, Meiji Seika to conduct P1 trial for Stelara biosimilar
Dong-A Socio Holdings and Meiji Seika Pharmaceutical said they have started...
by Lee Han-soo  |  2019-12-16 17:01
라인
Huons Lab, Pangen to codevelop human genetic recombinant hyaluronidase
Huons Lab, a subsidiary of Huons, said that it would cooperate in developin...
by Lee Han-soo  |  2019-12-16 15:23
라인
KDA tells patients not to stop taking metformin arbitrarily
The Korean Diabetes Association (KDA) has warned diabetic patients against ...
by Lee Han-soo  |  2019-12-16 10:56
라인
GC, Add Pharma to co-develop synthetic drugs
GC said that it has agreed with Add Pharmaceutical to cooperate on developi...
by Lee Han-soo  |  2019-12-13 16:25
라인
Daewoong releases trial results for autoimmune disease treatment candidate
Daewoong Pharmaceutical said that it has presented the research results of ...
by Lee Han-soo  |  2019-12-13 15:12
라인
GC Labcell releases trial results of NK-cell combination treatment
GC Labcell has presented the preclinical trial data for new blood cancer tr...
by Lee Han-soo  |  2019-12-12 18:00
라인
Eli Lilly Korea launches migraine prevention drug
Eli Lilly said that it has officially launched Emgality, a migraine prevent...
by Lee Han-soo  |  2019-12-12 15:28
여백
여백
여백
Back to Top